For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased disease activity after vaccination. We aimed to assess changes in disease activity after SARS-CoV-2 vaccination in patients with IMIDs, and determine risk factors for increased disease activity. In this substudy of a prospective observational cohort study (Target-to-B!), we included patients with IMIDs who received a SARS-CoV-2 vaccine. Patients reported changes in disease activity on a five-point Likert scale every 60 days for up to twelve months after first vaccination. In case of self-reported increased activity, hospital records were screened whether the treating physician reported increased activity, and for potential intensification of immu...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron b...
Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron b...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron b...
Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron b...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
For patients with immune-mediated inflammatory diseases (IMIDs), concerns exist about increased dise...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
BACKGROUND: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs)...
Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron b...
Objectives To compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron b...